The acute phase is not the only stage of stroke that has to be managed. Prevention of stroke is extremely important, whether it is primary or secondary. This section provides links to websites containing more information on this subject.
The risk of having a recurrent stroke increases dramatically after a stroke or transient ischaemic attack. To learn more about the use of Aggrenox® (extended-release dipyridamole + ASA) in the secondary prevention of ischaemic stroke, please go to:
Prevention of stroke in patients with atrial fibrillation
Pradaxa is a non-vitamin K oral anticoagulant (NOAC) and the only direct thrombin inhibitor for the prevention of stroke in patients with atrial fibrillation.
The product website for Pradaxa was developed for healthcare professionals to provide information on clinical trials, patient types, indications and dosing, as well as the latest news and guidance on how to use the dabigatran-specific reversal agent, Praxbind, in emergency situations.
STOPstroke is an information website for patients, designed to provide them with a better understanding of atrial fibrillation (AF), how AF increases the risk of stroke, as well as the importance of communication with between doctor and patient in order to optimise management and adherence. The website provides general information on AF and stroke, available treatments, and how patients can work in partnership with their doctor. In addition, STOPstroke also contains a multimedia series, with videos discussing a number of topics.